Skip to content

Wave Life Sciences WVE Change in Prepaids

Change in Prepaids at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$42K+700%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$7.36M-287%

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's change in prepaids.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's change in prepaids?
Wave Life Sciences (WVE) reported change in prepaids of $4.83M in Q1 2026.
How has Wave Life Sciences's change in prepaids changed year-over-year?
Wave Life Sciences's change in prepaids increased by 425.9% year-over-year, from -$1.48M to $4.83M.
What is the long-term trend for Wave Life Sciences's change in prepaids?
Over 2 years (2021 to 2024), Wave Life Sciences's change in prepaids has grown at a -69.1% compound annual growth rate (CAGR), from -$3.85M to -$368K.
What does change in prepaids mean?
This metric measures the net change in payments made in advance for goods or services that will be consumed in future periods. An increase in this balance indicates cash outflows ahead of expense recognition, while a decrease reflects the utilization of previously paid assets. It is a key indicator of short-term working capital management and timing of operational expenditures.